Correlation Between Tscan Therapeutics and Viemed Healthcare
Can any of the company-specific risk be diversified away by investing in both Tscan Therapeutics and Viemed Healthcare at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tscan Therapeutics and Viemed Healthcare into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Tscan Therapeutics and Viemed Healthcare, you can compare the effects of market volatilities on Tscan Therapeutics and Viemed Healthcare and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tscan Therapeutics with a short position of Viemed Healthcare. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tscan Therapeutics and Viemed Healthcare.
Diversification Opportunities for Tscan Therapeutics and Viemed Healthcare
-0.3 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Tscan and Viemed is -0.3. Overlapping area represents the amount of risk that can be diversified away by holding Tscan Therapeutics and Viemed Healthcare in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Viemed Healthcare and Tscan Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tscan Therapeutics are associated (or correlated) with Viemed Healthcare. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Viemed Healthcare has no effect on the direction of Tscan Therapeutics i.e., Tscan Therapeutics and Viemed Healthcare go up and down completely randomly.
Pair Corralation between Tscan Therapeutics and Viemed Healthcare
Given the investment horizon of 90 days Tscan Therapeutics is expected to generate 2.59 times more return on investment than Viemed Healthcare. However, Tscan Therapeutics is 2.59 times more volatile than Viemed Healthcare. It trades about 0.06 of its potential returns per unit of risk. Viemed Healthcare is currently generating about 0.03 per unit of risk. If you would invest 210.00 in Tscan Therapeutics on August 29, 2024 and sell it today you would earn a total of 254.00 from holding Tscan Therapeutics or generate 120.95% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Tscan Therapeutics vs. Viemed Healthcare
Performance |
| Timeline |
| Tscan Therapeutics |
| Viemed Healthcare |
Tscan Therapeutics and Viemed Healthcare Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Tscan Therapeutics and Viemed Healthcare
The main advantage of trading using opposite Tscan Therapeutics and Viemed Healthcare positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tscan Therapeutics position performs unexpectedly, Viemed Healthcare can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Viemed Healthcare will offset losses from the drop in Viemed Healthcare's long position.| Tscan Therapeutics vs. Apellis Pharmaceuticals | Tscan Therapeutics vs. Iteos Therapeutics | Tscan Therapeutics vs. Day One Biopharmaceuticals | Tscan Therapeutics vs. Acumen Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Other Complementary Tools
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |